4.7 Article

Chemical Endoplasmic Reticulum Chaperone Alleviates Doxorubicin-Induced Cardiac Dysfunction

期刊

CIRCULATION RESEARCH
卷 118, 期 5, 页码 798-809

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.115.307604

关键词

doxorubicin; endoplasmic reticulum chaperone; cardiac dysfunction; apoptosis; endoplasmic reticulum stress

资金

  1. Ministry of Education, Culture, Sports, Science, and Technology of Japan
  2. Grants-in-Aid for Scientific Research [15H04821, 15K12542] Funding Source: KAKEN

向作者/读者索取更多资源

Rationale: Doxorubicin is an effective chemotherapeutic agent for cancer, but its use is often limited by cardiotoxicity. Doxorubicin causes endoplasmic reticulum (ER) dilation in cardiomyocytes, and we have demonstrated that ER stress plays important roles in the pathophysiology of heart failure. Objective: We evaluated the role of ER stress in doxorubicin-induced cardiotoxicity and examined whether the chemical ER chaperone could prevent doxorubicin-induced cardiac dysfunction. Methods and Results: We confirmed that doxorubicin caused ER dilation in mouse hearts, indicating that doxorubicin may affect ER function. Doxorubicin activated an ER transmembrane stress sensor, activating transcription factor 6, in cultured cardiomyocytes and mouse hearts. However, doxorubicin suppressed the expression of genes downstream of activating transcription factor 6, including X-box binding protein 1. The decreased levels of X-box binding protein 1 resulted in a failure to induce the expression of the ER chaperone glucose-regulated protein 78 which plays a major role in adaptive responses to ER stress. In addition, doxorubicin activated caspase-12, an ER membrane-resident apoptotic molecule, which can lead to cardiomyocyte apoptosis and cardiac dysfunction. Cardiac-specific overexpression of glucose-regulated protein 78 by adeno-associated virus 9 or the administration of the chemical ER chaperone 4-phenylbutyrate attenuated caspase-12 cleavage, and alleviated cardiac apoptosis and dysfunction induced by doxorubicin. Conclusions: Doxorubicin activated the ER stress-initiated apoptotic response without inducing the ER chaperone glucose-regulated protein 78, further augmenting ER stress in mouse hearts. Cardiac-specific overexpression of glucose-regulated protein 78 or the administration of the chemical ER chaperone alleviated the cardiac dysfunction induced by doxorubicin and may facilitate the safe use of doxorubicin for cancer treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

Post-ablation left atrial function impacts long-term recurrence of atrial fibrillation after ablation

Takafumi Oka, Yasushi Koyama, Koji Tanaka, Yuko Hirao, Nobuaki Tanaka, Masato Okada, Issei Yoshimoto, Ryo Kitagaki, Atsunori Okamura, Katsuomi Iwakura, Yasushi Sakata, Kenshi Fujii, Koichi Inoue

Summary: Left atrial (LA) function is crucial in predicting cardiovascular events, and post-ablation LA function influences the recurrence of atrial fibrillation (AF). Reduced post-ablation LA emptying fraction may be associated with AF recurrence, with predictors being low pre-ablation LA function, high pre-ablation LA volume, low body mass index, and female sex. Additional ablation sessions and extra-pulmonary vein LA ablation may also contribute to reduced LA function post-ablation.

HEART AND VESSELS (2022)

Article Medicine, Research & Experimental

Real-World Safety and Effectiveness of Canagliflozin Treatment for Type 2 Diabetes Mellitus in Japan: SAPPHIRE, a Long-Term, Large-Scale Post-Marketing Surveillance

Nobuya Inagaki, Masaomi Nangaku, Yasushi Sakata, Kazuyo Sasaki, Kazumi Mori-Anai, Tomohisa Iwasaki, Koume Hamada

Summary: Canagliflozin, a SGLT2 inhibitor, was found to provide sustained glucose-lowering effects in patients with type 2 diabetes during a 3-year post-marketing surveillance in Japan. Adverse drug reactions mainly included volume depletion and infections, with higher frequencies in elderly and patients with renal impairment. The drug showed improvements in HbA1c, with no new safety concerns observed beyond the information in the package insert.

ADVANCES IN THERAPY (2022)

Article Cardiac & Cardiovascular Systems

Comparison of Low-Dose Direct Oral Anticoagulants for Patients < 80 Versus >= 80 Years of Age With Atrial Fibrillation

Shun Sasaki, Yohei Sotomi, Akio Hirata, Nobuhiko Makino, Takaharu Hayashi, Yasushi Sakata, Atsushi Hirayama, Yoshiharu Higuchi

Summary: The study shows that in older patients, low-dose direct oral anticoagulant is associated with decreased risk of major bleeding without compromising efficacy. In younger patients, low-dose DOAC did not increase the risk of major bleeding or stroke/systemic embolism.

AMERICAN JOURNAL OF CARDIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Antithrombotic Therapy for Patients With Atrial Fibrillation and Bioprosthetic Valves-Real-World Data From the Multicenter, Prospective, Observational BPV-AF Registry

Chisato Izumi, Makoto Miyake, Tomoyuki Fujita, Tadaaki Koyama, Hidekazu Tanaka, Kenji Ando, Tatsuhiko Komiya, Masaki Izumo, Hiroya Kawai, Kiyoyuki Eishi, Kiyoshi Yoshida, Takeshi Kimura, Ryuzo Nawada, Tomohiro Sakamoto, Yoshisato Shibata, Toshihiro Fukui, Kenji Minatoya, Kenichi Tsujita, Yasushi Sakata, Misa Takegami, Tetsuya Kimura, Kumiko Sugio, Atsushi Takita, Kunihiro Nishimura, Yutaka Furukawa

Summary: This study investigated the antithrombotic therapy and thrombotic and hemorrhagic event rates in Japanese patients with atrial fibrillation (AF) and bioprosthetic valve (BPV) replacement. The results showed that there was no significant difference in the risk of major bleeding and stroke or systemic embolism between patients treated with direct oral anticoagulants (DOACs) and those treated with warfarin. Therefore, DOACs could be considered as an alternative to warfarin in this patient population.

CIRCULATION JOURNAL (2022)

Article Cell & Tissue Engineering

Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes

Hiroyuki Inoue, Satoki Nakamura, Shuichiro Higo, Mikio Shiba, Yasuaki Kohama, Takumi Kondo, Satoshi Kameda, Tomoka Tabata, Shota Okuno, Yoshihiko Ikeda, Junjun Li, Li Liu, Satoru Yamazaki, Maki Takeda, Emiko Ito, Seiji Takashima, Shigeru Miyagawa, Yoshiki Sawa, Shungo Hikoso, Yasushi Sakata

Summary: Isogenic induced pluripotent stem cell-derived cardiomyocytes with precisely adjusted expression of plakophilin-2 from a patient with arrhythmogenic cardiomyopathy were generated, successfully recapitulating the disease pathology and providing proof of concept for gene replacement therapy.

STEM CELL REPORTS (2022)

Article Cardiac & Cardiovascular Systems

Prognostic significance of serum chloride level in heart failure patients with preserved ejection fraction

Masahiro Seo, Tetsuya Watanabe, Takahisa Yamada, Masamichi Yano, Takaharu Hayashi, Akito Nakagawa, Yusuke Nakagawa, Shunsuke Tamaki, Yoshio Yasumura, Yohei Sotomi, Shungo Hikoso, Daisaku Nakatani, Masatake Fukunami, Yasushi Sakata

Summary: This study aimed to investigate the relationship between serum chloride level and clinical outcomes in patients with heart failure with preserved ejection fraction (HFpEF) with acute decompensated heart failure (ADHF). The study found that serum chloride level was significantly associated with right ventricular systolic dysfunction at discharge, and it was independently associated with all-cause mortality after adjusting for major confounders. The results suggest that serum chloride level is a useful predictor of poor outcomes in HFpEF patients.

ESC HEART FAILURE (2022)

Review Cardiac & Cardiovascular Systems

JCS/JSCVS/JATS/JSVS 2021 Guideline on Implantable Left Ventricular Assist Device for Patients With Advanced Heart Failure

Minoru Ono, Osamu Yamaguchi, Tomohito Ohtani, Koichiro Kinugawa, Yoshikatsu Saiki, Yoshiki Sawa, Akira Shiose, Hiroyuki Tsutsui, Norihide Fukushima, Goro Matsumiya, Masanobu Yanase, Kenji Yamazaki, Kazuhiro Yamamoto, Masatoshi Akiyama, Teruhiko Imamura, Kiyotaka Iwasaki, Miyoko Endo, Yoshihiko Ohnishi, Takahiro Okumura, Koichi Kashiwa, Osamu Kinoshita, Kaori Kubota, Osamu Seguchi, Koichi Toda, Hiroshi Nishioka, Tomohiro Nishinaka, Takashi Nishimura, Toru Hashimoto, Masaru Hatano, Haruhiko Higashi, Taiki Higo, Takeo Fujino, Yumiko Hori, Toru Miyoshi, Motoharu Yamanaka, Takayuki Ohno, Takeshi Kimura, Shunei Kyo, Yasushi Sakata, Takeshi Nakatani

CIRCULATION JOURNAL (2022)

Article Cardiac & Cardiovascular Systems

1-Year Outcomes of Fluoropoymer-Based Drug-Eluting Stent in Femoropopliteal Practice Predictors of Restenosis and Aneurysmal Degeneration

Osamu Iida, Mitsuyoshi Takahara, Yoshimitsu Soga, Terutoshi Yamaoka, Masahiko Fujihara, Daizo Kawasaki, Shigeo Ichihashi, Amane Kozuki, Shinsuke Nanto, Yasushi Sakata, Toshiaki Mano

Summary: This study investigated the 1-year risk of restenosis and aneurysmal degeneration after femoropopliteal implantation of FP-DES for symptomatic atherosclerotic peripheral artery disease. It found that the 1-year restenosis rate was acceptable, but occlusive restenosis and aneurysmal degeneration should be noted.

JACC-CARDIOVASCULAR INTERVENTIONS (2022)

Article Cardiac & Cardiovascular Systems

Relation of left atrial overload indices with prognostic endpoints in heart failure and preserved ejection fraction

Shiro Hoshida, Koichi Tachibana, Yukinori Shinoda, Tomoko Minamisaka, Masahiro Seo, Masamichi Yano, Takaharu Hayashi, Akito Nakagawa, Yusuke Nakagawa, Shunsuke Tamaki, Takahisa Yamada, Yoshio Yasumura, Yohei Sotomi, Shungo Hikoso, Daisaku Nakatani, Yasushi Sakata

Summary: This study aimed to clarify the association between prognostic endpoints and left atrial overload indices in elderly patients with HFpEF. The results showed that SV/LAV was a significant prognostic factor for heart failure re-admission, while Ed/Ea was a significant prognostic factor for all-cause mortality in these patients.

ESC HEART FAILURE (2022)

Article Urology & Nephrology

Preoperative hypomagnesemia as a possible predictive factor for postoperative increase of transvalvular pressure gradient in hemodialysis patients treated with transcatheter aortic valve implantation

Satoshi Masuyama, Masayuki Mizui, Koichi Maeda, Kazuo Shimamura, Yusuke Sakaguchi, Masashi Morita, Toru Kuratani, Isamu Mizote, Daisuke Nakamura, Yasushi Sakata, Yoshiki Sawa, Shigeru Miyagawa, Yoshitaka Isaka

Summary: This study analyzed the association between preoperative clinical factors and valve stenosis after transcatheter aortic valve implantation (TAVI) in patients undergoing maintenance hemodialysis (HD). The results showed that low serum magnesium levels were associated with an increase in aortic transvalvular pressure gradient after TAVI. This suggests that hypomagnesemia could predict post-TAVI valve dysfunction in HD patients.

RENAL FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Clinical impact of blood urea nitrogen, regardless of renal function, in heart failure with preserved ejection fraction

Masamichi Yano, Masami Nishino, Kohei Ukita, Akito Kawamura, Hitoshi Nakamura, Yutaka Matsuhiro, Koji Yasumoto, Masaki Tsuda, Naotaka Okamoto, Yasuharu Matsunaga-Lee, Yasuyuki Egami, Jun Tanouchi, Takahisa Yamada, Yoshio Yasumura, Shunsuke Tamaki, Takaharu Hayashi, Akito Nakagawa, Yusuke Nakagawa, Yohei Sotomi, Daisaku Nakatani, Shungo Hikoso, Yasushi Sakata

Summary: This study found that blood urea nitrogen (BUN) has an important impact on the prognosis of patients with heart failure with preserved ejection fraction (HFpEF). Regardless of renal function, the level of BUN is associated with the risk of HF readmission and all-cause death. In addition, BUN level is also correlated with left atrial function in HFpEF patients.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)

Article Medicine, General & Internal

Impact of Sex in Left Atrial Indices for Prognosis of Heart Failure with Preserved Ejection Fraction

Shiro Hoshida, Koichi Tachibana, Nobutaka Masunaga, Yukinori Shinoda, Tomoko Minamisaka, Hirooki Inui, Keisuke Ueno, Masahiro Seo, Masamichi Yano, Takaharu Hayashi, Akito Nakagawa, Yusuke Nakagawa, Shunsuke Tamaki, Takahisa Yamada, Yoshio Yasumura, Yohei Sotomi, Shungo Hikoso, Daisaku Nakatani, Yasushi Sakata

Summary: This study aimed to investigate the differences in the association between re-admission for HF and LA overload indices by sex in HFpEF patients. The results showed that LA overload was an important prognostic factor for HF re-admission, and this overload differed by sex.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Multifactorial effects of outpatient cardiac rehabilitation in patients with heart failure: a nationwide retrospective cohort study

Koshiro Kanaoka, Yoshitaka Iwanaga, Michikazu Nakai, Yuichi Nishioka, Tomoya Myojin, Shinichiro Kubo, Katsuki Okada, Tatsuya Noda, Yasushi Sakata, Yoshihiro Miyamoto, Yoshihiko Saito, Tomoaki Imamura

Summary: This study investigated the effects of outpatient cardiac rehabilitation in patients with heart failure using a nationwide database. The results showed that outpatient cardiac rehabilitation was associated with a reduction in mortality and rehospitalization for heart failure without increasing medical costs.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Avoiding unnecessary ventricular pacing is associated with reduced incidence of heart failure hospitalizations and persistent atrial fibrillation in pacemaker patients

Martin Arnold, Mark Richards, Antonio D'Onofrio, Brett Faulknier, Michele Gulizia, Ranjan Thakur, Yasushi Sakata, Wenjiao Lin, Annalisa Pollastrelli, Andrea Grammatico, Angelo Auricchio, Giuseppe Boriani

Summary: In bradycardia patients treated with dual-chamber pacing, pacing with AV delay management (AVH) reduces unnecessary ventricular pacing percentage (VPP) and is associated with better clinical outcomes.

EUROPACE (2023)

Article Cardiac & Cardiovascular Systems

Sodium-glucose cotransporter 2 inhibitor use in early-phase acute coronary syndrome with severe heart failure

Koshiro Kanaoka, Yoshitaka Iwanaga, Michikazu Nakai, Yuichi Nishioka, Tomoya Myojin, Shinichiro Kubo, Katsuki Okada, Tatsuya Noda, Yasushi Sakata, Yoshihiro Miyamoto, Yoshihiko Saito, Tomoaki Imamura

Summary: This retrospective cohort study examined the association of early use of SGLT2 inhibitors with outcomes in hospitalized patients with acute coronary syndrome. The results showed that SGLT2 inhibitors were associated with a lower risk of the primary outcome in patients with severe heart failure, but not in patients without severe heart failure.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2023)

暂无数据